Exin Therapeutics
PrivateLast Round
Seed
May 20, 2025
Total Funding Raised
$500,000
Company Overview
Exin Therapeutics is a healthcare technology company developing a genetic therapy and AI discovery platform intended to target neurological and neuropsychiatric disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exin Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Exin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 20, 2025 |
Key People
Founding team and executive leadership
Exin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Seed |
| Tekedia Capital | Seed |
Exin Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exin Therapeutics's valuation, stock price, and market status.
